NURTURE’s uniqueness lies in the combination of AI-enhanced placental organoid multi-omics and clinical data that enables early predictive readouts for in vitro drug testing. The focus on pregnancy-related diseases and integration of clinical and in vitro data makes it a pioneering solution.
Co-operations with national and international partners for data sharing and development (e.g. other hospitals, biobanks, fertility centers)
Product Manager, Business Advisor from the Drug Development field, Software Developer.
